TITLE

Brand, bottle size, overflow affect annual cost of glaucoma drugs

AUTHOR(S)
Boyle, Erin L.
PUB. DATE
July 2008
SOURCE
Ocular Surgery News;7/10/2008, Vol. 26 Issue 13, p21
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on a study which found that drug brand and bottle size can have an effect on the cost and amount of glaucoma medication that patients receive and could be considered a factor in choosing a therapy. Among glaucoma medications in various bottle sizes examined in the study include prostaglandin analogues and Cosopt. The study found that generic timolol had the lowest annual cost while Alphagan P had the highest yearly cost.
ACCESSION #
32766857

 

Related Articles

  • Should Prostaglandins Be on the Frontlines? Crandall, Alan // Review of Ophthalmology;Feb2002, Vol. 9 Issue 2, p49 

    Evaluates prostaglandins and related agents for the treatment of glaucoma in the U.S. Objectives of glaucoma therapy; Ability of the beta-blocker timolol to reduce intraocular pressure (IOP); Reliability of sympathomimetic in the reduction of IOP; Complications from the use of...

  • Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model. Stewart, W. C.; Stewart, J. A.; Mychaskiw, M. A. // Eye;Jan2009, Vol. 23 Issue 1, p132 

    PurposeTo assess the cost-effectiveness of latanoprost or timolol in glaucoma treatment in Norway, Sweden, Denmark (Scandinavia) and the United Kingdom (UK).MethodsA Markov model was constructed to perform a cost-effectiveness analysis. Health states were ‘stable’ and...

  • Bimatoprost/timolol of value for glaucoma in Europe.  // PharmacoEconomics & Outcomes News;4/19/2008, Issue 551, p5 

    The article discusses research being done on the use of fixed-combination therapies in open-angle glaucoma patients. It references a study by A. Hommer, M. M. Friis et al published in the April 2008 issue of "Current Medical Research and Opinion." It notes the cost-effectiveness of a fixed-dose...

  • GLAUCOMA.  // Review of Optometry;6/15/2008 Clinical Guide to Ophthac, Vol. 145, p46A 

    The article focuses on the medical therapeutic aspects of caring patients with glaucoma. It states that glaucoma employs diagnostic and therapeutic methods for superb care on patients. On the other hand, prostaglandin or timolol could be best prescribed for patients with ocular hypotensive...

  • Fixed-Combination Brimonidine/Timolol as Adjunctive Therapy to a Prostaglandin Analog: A 3-Month, Open-Label, Replacement Study in Glaucoma Patients. Nguyen, Quang H.; Earl, Melissa // Journal of Ocular Pharmacology & Therapeutics;Dec2009, Vol. 25 Issue 6, p541 

    Purpose: To evaluate intraocular pressure (IOP) and ocular allergy after replacement of 1 of 2 adjunctive therapy regimens (fixed-combination dorzolamide/timolol or dorzolamide/timolol plus brimonidine) with fixed-combination brimonidine/timolol in glaucoma patients treated with ongoing...

  • Xalacom. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p809 

    A encyclopedia entry for "Xalacom" is presented. It refers to the brand-name of prostaglandin drug which contains latanoprost and timolol. Xalacom can be used as eye-drops in the treatment of glaucoma cases wherein the fluid in the eyeball in under increased pressure. Xalacom is classified under...

  • New mindset suggested for prescribing beta-blockers. Lama, Paul J. // Ophthalmology Times;3/15/2002, Vol. 27 Issue 6, p8 

    Focuses on the effectiveness of beta-blocker timolol maleate for glaucoma patients. Development of glaucoma medications; Protection of the heart muscle tissue; Suppression of catecholamine stimulation.

  • Effect of Changing From Concomitant Timolol Pilocarpine to Bimatoprost Monotherapy on Ocular Blood Flow and IOP in Primary Chronic Angle Closure Glaucoma. Agarwal, Harish C.; Gupta, Viney; Sihota, Ramanjit // Journal of Ocular Pharmacology & Therapeutics;Apr2003, Vol. 19 Issue 2, p105 

    The aim of the present prospective masked study was to assess the effect of bimatoprost monotherapy on ocular blood flow and intraocular pressure (IOP) in eyes of primary chronic angle closure glaucoma patients already on concomitant timolol and pilocarpine. Thirty two patients of bilateral...

  • Comparison of the Efficacy of the Fixed-Combination Timolol/Dorzolamide Versus Concomitant Administration of Timolol and Dorzolamide. Bacharach, Jason; Delgado, Maria F.; Iwach, Andrew G. // Journal of Ocular Pharmacology & Therapeutics;Apr2003, Vol. 19 Issue 2, p93 

    The purpose of this study was to compare the efficacy of the fixed-combination solution of timolol 0.5%/dorzolamide 2% with the concomitant administration of its components, timolol 0.5% twice a day and dorzolamide 2% twice a day. Ninety-eight patients adequately controlled with a concomitant...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics